A Web-Based Clinical System for Cohort Surveillance of Specific Clinical Effectiveness and Safety Outcomes: A Cohort Study of Non–Vitamin K Antagonist Oral Anticoagulants and Warfarin
Authors:
- Fong-Ci LinFLFong-Ci Lin
- Shih-Tsung HuangSHShih-Tsung Huang
- Rung Ji ShangRSRung Ji Shang
- Chi-Chuan WangCWChi-Chuan Wang
- Fei-Yuan HsiaoFHFei-Yuan Hsiao
- Fang-Ju LinFLFang-Ju Lin
- Mei-Shu LinMLMei-Shu Lin
- Kuan-Yu HungKHKuan-Yu Hung
- Jui WangJWJui Wang
- Li-Jiuan ShenLSLi-Jiuan Shen
- Feipei LaiFLFeipei Lai
- Chih-Fen HuangCHChih-Fen Huang
Open Access
- 3 July 2019
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 7 (3) , e13329
Abstract
Background: Conventional systems of drug surveillance lack a seamless workflow, which makes it crucial to have an active drug surveillance system that proactively assesses adverse drug events. Objective: The aim of this study was to develop a seamless, Web-based workflow for comparing the safety and effectiveness of drugs in a database of electronic medical records. Methods: We proposed a comprehensive integration process for cohort surveillance using the National Taiwan University Hospital Clinical Surveillance System (NCSS). We studied a practical application of the NCSS that evaluates the drug safety and effectiveness of novel oral anticoagulants (NOACs) and warfarin by cohort tree analysis in an efficient and interoperable platform. Results: We demonstrated a practical example of investigating the differences in effectiveness and safety between NOACs and warfarin in patients with nonvalvular atrial fibrillation (AF) using the NCSS. We efficiently identified 2357 patients with nonvalvular AF with newly prescribed oral anticoagulants between 2010 and 2015 and further developed 1 main cohort and 2 subcohorts for separately measuring ischemic stroke as the clinical effectiveness outcome and intracranial hemorrhage (ICH) as the safety outcome. In the subcohort of ischemic stroke, NOAC users exhibited a significantly lower risk of ischemic stroke than warfarin users after adjusting for age, sex, comorbidity, and comedication in an intention-to-treat (ITT) analysis (P=.01) but did not exhibit a significantly distinct risk in an as-treated (AT) analysis (P=.12) after the 2-year follow-up. In the subcohort of ICH, NOAC users did not exhibit a different risk of ICH both in ITT (P=.68) and AT analyses (P=.15). Conclusions: With a seamless and Web-based workflow, the NCSS can serve the critical role of forming associations between evidence and the real world at a medical center in Taiwan.Keywords
This publication has 32 references indexed in Scilit:
- Drug safety assessment in clinical trials: methodological challenges and opportunitiesTrials, 2012
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational StudiesMedical Decision Making, 2009
- Intention to treat, per protocol, as treated and instrumental variable estimators given non‐compliance and effect heterogeneityStatistics in Medicine, 2009
- Comparison of different matching methods in observational studies and sensitivity analysis: The relation between depression and STAI-2 scoresExpert Systems with Applications, 2009
- Intent-to-treat vs. Non-intent-to-treat Analyses under Treatment Non-adherence in Mental Health Randomized TrialsPsychiatric Annals, 2008
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial FibrillationCirculation, 2007
- Comparison of evidence on harms of medical interventions in randomized and nonrandomized studiesCanadian Medical Association Journal, 2006